Mayne Pharma | MYX - Current Assets

Stock Price
4.50
Daily Change
-0.78 -14.77%
Monthly
-10.00%
Yearly
-6.44%
Q3 Forecast
5.25

Mayne Pharma reported AUD460.59M in Current Assets for its fiscal semester ending in June of 2024.



Financials
Stock Price AUD
Assets AUD 1.14B
Cash and Equivalent AUD 110.07M
Cost of Sales AUD 43.74M
Current Assets AUD 460.59M
Current Liabilities AUD 313.94M
Debt AUD 38.82M
Dividend Yield 0
EBIT AUD -16.2M
EBITDA AUD -65.76M
Employees 900
EPS Earnings Per Share AUD -0.89
Equity Capital and Reserves AUD 454.19M
Gross Profit on Sales AUD 115.99M
Interest Expense on Debt AUD 1.2M
Loan Capital AUD 31.64M
Market Capitalization AUD 382.83M
Net Income AUD -103.68M
Operating Expenses AUD 103.54M
Operating Profit AUD -3.3M
Ordinary Share Capital AUD 1.22B
Pre-Tax Profit AUD -57.61M
Sales Revenues AUD 195.04M
Selling and Administration Expenses AUD 54.8M
Stock AUD 74.63M
Trade Creditors AUD 20.87M
Trade Debtors AUD 193.22M

Current Assets Change Date
Ansell USD 1.62B 732.9M Jun/2024
Avita Medical AUD 57M 15.96M Dec/2024
Cochlear AUD 1.41B 41.5M Dec/2024
CSL USD 11.31B 540M Dec/2024
Healius AUD 1.04B 737.9M Dec/2024
Integral Diagnostics AUD 74.82M 9.15M Jun/2024
Medical Developments International AUD 33.41M 7.26M Dec/2024
Nanosonics AUD 210.09M 11.64M Dec/2024
Next Science USD 6.05M 2.13M Dec/2024
Polynovo AUD 79.3M 9.02M Jun/2024
Ramsay Health Care AUD 3.41B 465.3M Dec/2024
ResMed USD 3.51B 669.42M Jun/2025
Sigma Healthcare AUD 1.22B 310.88M Jul/2024
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Telix Pharmaceuticals AUD 918.56M 663.3M Dec/2024